...
首页> 外文期刊>Journal of Materials Chemistry, B. materials for biology and medicine >Aptamer application in targeted delivery systems for diagnosis and treatment of breast cancer
【24h】

Aptamer application in targeted delivery systems for diagnosis and treatment of breast cancer

机译:适体在乳腺癌的靶向治疗系统中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Breast cancer is the second leading cause, of cancer deaths in women and, due to its diverse morphological features, variable clinical outcome and response to different therapeutic options, is known as a highly heterogeneous disease. Aptamers are a class of therapeutic oligonucleotides that are rapidly generated through the SELEX (Systematic Evolution of Ligands by EXponential enrichment) process. The unique properties of aptamers such as high binding affinity and selectivity, low or no immunogenicity and toxicity, low cost and thermal stability make them good potential pharmaceutical agents. In this review, we present the recent progress of aptamer application in targeted delivery systems for imaging and treatment of breast cancer. Furthermore, some analytical approaches such as electrochemical and optical aptasensors are introduced for the detection and diagnosis of breast cancer. Finally, we discuss the problems and challenges of aptamer application in this field.
机译:乳腺癌是女性癌症死亡的第二大主要原因,由于其形态特征多样,临床结果可变以及对不同治疗选择的反应,被称为高度异质性疾病。适体是一类治疗性寡核苷酸,其通过SELEX(通过指数富集的配体系统进化)过程快速产生。适体的独特性质,例如高结合亲和力和选择性,低或无免疫原性和毒性,低成本和热稳定性,使其成为良好的潜在药物。在这篇综述中,我们介绍了适体在靶向成像和乳腺癌治疗系统中的应用进展。此外,引入了一些分析方法,例如电化学和光学适体传感器,用于乳腺癌的检测和诊断。最后,我们讨论了适体在该领域应用的问题和挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号